Large-scale stopping and switching treatment with COX-2 inhibitors after the rofecoxib withdrawal
Author:
Publisher
Wiley
Subject
Pharmacology (medical),Epidemiology
Reference30 articles.
1. Risk of Cardiovascular Events Associated With Selective COX-2 Inhibitors
2. Relationship Between Selective Cyclooxygenase-2 Inhibitors and Acute Myocardial Infarction in Older Adults
3. Comparison of Upper Gastrointestinal Toxicity of Rofecoxib and Naproxen in Patients with Rheumatoid Arthritis
4. Cardiovascular Events Associated with Rofecoxib in a Colorectal Adenoma Chemoprevention Trial
5. FDA. http://www.fda.gov/cder/drug/advisory/COX2.htmon. In 2006.
Cited by 21 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Communicating Drug Safety;Principles and Practice of Pharmacovigilance and Drug Safety;2024
2. QR code and mobile payment: The disruptive forces in retail;Journal of Retailing and Consumer Services;2021-01
3. COX-2 Inhibitors: Communication of Accumulating Risk Evidence and a Product Withdrawal;Communicating about Risks and Safe Use of Medicines;2020
4. Towards understanding the de-adoption of low-value clinical practices: a scoping review;BMC Medicine;2015-10-06
5. Actions following adverse drug events – how do these influence uptake and utilisation of newer and/or similar medications?;BMC Health Services Research;2015-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3